A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.

A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.

他のバージョン（1件）を表示する

OBJECTIVES: This report reviews the clinical effectiveness and cost-effectiveness of adalimumab, etanercept and infliximab, agents that inhibit tumour necrosis factor-alpha (TNF-alpha), when used in the treatment of rheumatoid arthritis (RA) in adults. DATA SOURCES: Electronic databases were search...

書誌詳細
主要な著者:	Chen, Y, Jobanputra, P, Barton, P, Jowett, S, Bryan, S, Clark, W, Fry-Smith, A, Burls, A
フォーマット:	Journal article
言語:	English
出版事項:	2006

類似資料

A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness
著者:: Chen, Y, 等
出版事項: (2006)

The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: A systematic review and economic evaluation
著者:: Jobanputra, P, 等
出版事項: (2002)

The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: a systematic review and economic evaluation.
著者:: Jobanputra, P, 等
出版事項: (2002)

The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: a systematic review and economic evaluation
著者:: P. Jobanputra, 等
出版事項: (2002-01-01)

Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a tumour necrosis factor inhibitor: a systematic review and economic evaluation
著者:: K Malottki, 等
出版事項: (2011-03-01)

Effectiveness of dose reduction of etanercept and adalimumab in patients with rheumatoid arthritis
著者:: Martínez-Pérez Rosalía, 等
出版事項: (2011-11-01)

The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis
著者:: Clark, W, 等
出版事項: (2004)

The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis.
著者:: Clark, W, 等
出版事項: (2004)

The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis.
著者:: Clark, W, 等
出版事項: (2004)

The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis
著者:: W Clark, 等
出版事項: (2004-09-01)

Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis: a systematic review and economic evaluation
著者:: M Rodgers, 等
出版事項: (2011-02-01)

Etanercept for the treatment of rheumatoid arthritis.
著者:: Lethaby, A, 等
出版事項: (2013)

Etanercept for the treatment of rheumatoid arthritis.
著者:: Blumenauer, B, 等
出版事項: (2003)

Etanercept for the treatment of rheumatoid arthritis
著者:: Blumenauer, B, 等
出版事項: (2004)

Mapping the certolizumab pegol epitope on TNF and comparison with infliximab, adalimumab and etanercept
著者:: Henry Alistair I, 等
出版事項: (2011-11-01)

Infliximab for the treatment of rheumatoid arthritis.
著者:: Blumenauer, B, 等
出版事項: (2002)

Clinical and economic efficiency to reduce dose etanercept and adalimumab in patients with rheumatoid arthritis
著者:: Martínez-Pérez Rosalía, 等
出版事項: (2012-11-01)

Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation
著者:: C McLeod, 等
出版事項: (2007-08-01)

Comparison of drug survival on adalimumab, etanercept, golimumab and infliximab in patients with axial spondyloarthritis.
著者:: Monika Hebeisen, 等
出版事項: (2019-01-01)

Population Pharmacokinetic Analysis and Simulation of Alternative Dosing Regimens for Biosimilars to Adalimumab and Etanercept in Patients with Rheumatoid Arthritis
著者:: Stephanie F. Ling, 等
出版事項: (2024-05-01)

A systematic review of effectiveness and economic evaluation of new drug treatments for juvenile idiopathic arthritis: etanercept.
著者:: Cummins, C, 等
出版事項: (2002)

A systematic review of effectiveness and economic evaluation of new drug treatments for juvenile idiopathic arthritis: etanercept.
著者:: Cummins, C, 等
出版事項: (2002)

A systematic review of effectiveness and economic evaluation of new drug treatments for juvenile idiopathic arthritis: etanercept
著者:: C. Cummins, 等
出版事項: (2002-01-01)

Decrease in articular hypoxia and synovial blood flow at early time points following infliximab and etanercept treatment in rheumatoid arthritis
著者:: Fisher, B, 等
出版事項: (2016)

Is drug discontinuation risk of adalimumab compared with etanercept affected by concomitant methotrexate dose in patients with rheumatoid arthritis?
著者:: Chen HH, 等
出版事項: (2016-02-01)

Cost-consequence analysis of tocilizumab versus adalimumab and etanercept among rheumatoid arthritis patients in Saudi Arabia: a single-center study
著者:: Areej S. Albahdal, 等
出版事項: (2024-02-01)

The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis.
著者:: Barton, P, 等
出版事項: (2004)

The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis.
著者:: Barton, P, 等
出版事項: (2004)

The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis
著者:: P Barton, 等
出版事項: (2004-03-01)

The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis - Introduction
著者:: Barton, P, 等
出版事項: (2004)

Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease.
著者:: Clark, W, 等
出版事項: (2003)

Systemic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease
著者:: Clark, W, 等
出版事項: (2003)

Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease.
著者:: Clark, W, 等
出版事項: (2003)

Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease
著者:: W. Clark, 等
出版事項: (2003-01-01)

Independent Candidate Serum Protein Biomarkers of Response to Adalimumab and to Infliximab in Rheumatoid Arthritis: An Exploratory Study.
著者:: Ignacio Ortea, 等
出版事項: (2016-01-01)

Infliximab in the treatment of rheumatoid arthritis
著者:: A Perdriger
出版事項: (2009-05-01)

The clinical effectiveness and cost-effectiveness of abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis: a systematic review and economic evaluation
著者:: Jonathan Shepherd, 等
出版事項: (2016-04-01)

Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation
著者:: N Woolacott, 等
出版事項: (2006-09-01)

Infliximab in the therapy of rheumatoid arthritis
著者:: G. V. Lukina, 等
出版事項: (2016-05-01)

Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.
著者:: Ruiz Garcia, V, 等
出版事項: (2011)